Carvedilol, a β adrenoceptor blocker with chelating properties. A copper 'superdimer' based on dimetal units

Journal of Inorganic Biochemistry

Volumn 95, Issue 4, 2003, Pages 315-320

  Zoroddu, Maria Antonietta ^a   Grepioni, Fabrizia ^a   Franconi, Flavia ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

Antioxidant drug; Carvedilol; Chelating; Cu(II)

Indexed keywords

CARVEDILOL; COPPER COMPLEX;

ARTICLE; CHELATION; CRYSTAL STRUCTURE; DRUG STRUCTURE; DRUG SYNTHESIS; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 0038462064     PISSN: 01620134     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-0134(03)00130-2     Document Type: Article

References (23)

1. Droge W. Physiol. Rev. 8:2002;47-95.
2. Fang Y.Z., Yang S., Wu G. Nutrition. 18:2002;872-879.
3. Llanos R.M., Mercer J.F. DNA Cell Biol. 21:2002;259-270.
4. Feurstein G.Z., Ruffolo R.R. Eur. Heart J. 16:1995;38-42.
5. Yue T.L., Cheng H.-Y., Lysko P.G., McKenna P.J., Feuerstein R., Fin J.L., Lysko K.A., Davis L.L., Feuerstein G. J. Pharmacol. Exp. Ther. 263:1992;92-98.
6. Tadolini B., Franconi F. Free Radic. Res. 29:1998;377-387.
7. Noguchi N., Nishino K., Niki E. Biochem. Pharmacol. 59:2000;1069-1076.
8. Oettl K., Greilberger J., Zangger K., Haslinger E., Reibnegger G., Jurgens G. Biochem. Pharmacol. 62:2001;241-248.
9. Yue T.L., Ma X.L., Gu J.L. J. Pharmacol. Exp. Ther. 273:1995;1442-1449.
10. Yue T.L., McKenna P.J., Lysko P.G., Ruffolo R.R., Feuerstein G.Z. Atherosclerosis. 97:1992;209-216.
11. Troy A.D., H Chaston C.H., Smith T.D., Pilbrow T.R. Inorg. Chem. 10:1971;2219-2221.
12. G.M. Sheldrick, SHELXL97, Program for Crystal Structure Determination, University of Göttingen, Germany, 1997.
13. E. Keller, SCHAKAL99, Graphical Representation of Molecular Models, University of Freiburg, Germany, 1999.
14. Fujimaki M., Hakusui H. Xenobiotica. 20:1990;1025-1034.
15. Bertini I., Luchinat C., Parigi G. Solution of NMR Paramagnetic Molecules. 2001;Elsevier, Amsterdam.
16. Levenson C.W. Am. J. Clin. Nutr. 67:1998;978S-981S.
17. Volker W., Dorszewski A., Unruh V., Robenek H., Breithardt G., Buddecke E. Atherosclerosis. 130:1997;29-36.
18. Evans P.J., Smith C., Mitchinson M.J., Halliwell B. Free Radic. Res. 23:1995;465-469.
19. Islam K.N., Takahashi M., Higashiyama S., Myint T., Uozumi N. J. Biochem. 118:1995;1054-1060.
20. Fox P.L., Mazumder B., Ehrenwald E., Mukhopadhyay C.K. Free Radic. Biol. Med. 28:2000;1735-1744.
21. Choi S.Y., Kwon H.Y., Kwon O.B., Eum W.S., Kang J.H. Biochimie. 82:2000;175-180.
22. E. von Mollendorff, G. Sponer, K. Strein, W. Bartsch, B. Muller-Beckmann, G. Neugebauer, H. Czerwek, G. Bode, E. Schnurr, in: A. Scriabine (Ed.), New Cardiovascular Drugs, Raven Press, New York, 1987, pp. 135-153.
23. von Mollendorff E., Reiff K. Eur. J. Clin. Pharmacol. 33:1987;511-513.